GlassScriptPhysician profile
Manisha Sahay
NPI 1629301890
$2,508.65
in general payments reported to CMS, 2019-2025
16 companies · $1,371 in 2025
The $1,371 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $192 · 2021: $113 · 2022: $25.25 · 2023: $401 · 2024: $87.00 · 2025: $1,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,250 · Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,250.00 |
| Food and Beverage | $608.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $1,250.00 | 2025 | Tarpeyo |
| Abbvie INC. | $230.63 | 2021-2025 | Botox |
| Acadia Pharmaceuticals INC | $166.42 | 2019-2023 | Nuplazid |
| Tg Therapeutics, INC. | $135.94 | 2023 | |
| Novartis Pharmaceuticals Corporation | $131.94 | 2019-2020 | |
| Genzyme Corporation | $112.37 | 2019 | |
| Biogen, INC. | $110.01 | 2023 | Vumerity, Tysabri |
| Medtronic USA, INC. | $95.69 | 2019 | |
| Pfizer INC. | $91.60 | 2025 | |
| Amgen INC. | $66.21 | 2019-2023 | Aimovig |
| Neurocrine Biosciences, INC. | $30.81 | 2023 | Ingrezza, Ongentys |
| Lundbeck LLC | $27.27 | 2024 | Vyepti |
| Abbott Laboratories | $20.66 | 2024 | Eterna |
| Currax Pharmaceuticals LLC | $14.85 | 2024 | Onzetra Xsail |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manisha Sahay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.